RE:Did CXR Overpay for Amdipharm Mercury...?We will know in 3 weeks. All on the table then. If the acquisition is (immediately or near term) accretive, then no, they did not over pay. Both sides understand value and I am certain they wanted to get a deal done. There was a PR done recently interviewing the party's lawyers. Worthy of a read. The bulk of the debt was paid with shares at USD$65 and long term debt at 4-5%. De-risked their business on a product and geopolitical basis, acquired 60 pipeline products, acquired global business platform.